AVAILABLE DOSSIERS - Approved in at least one EU country
Lyophilised powder for solution for infusion in glass vial
Acyclovir
Concentrate for solution for infusion in plastic ampoule blow-fill-seal
Amoxicillin/Clavulanic acid
Powder for solution for injection in glass vial
Cefepime
Powder for solution for injection in glass vial
Cefonicid
Powder and solvent for solution for injection in glass vial
Cefotaxime
Powder and solvent for solution for injection in glass vial
Powder and solvent for solution for injection/infusion in glass vial
Ceftazidime
Powder and solvent for solution for injection in glass vial
Powder for solution for infusion in glass vial
Ceftriaxone
Powder and solvent for solution for injection in glass vial
Powder for solution for infusion in glass vial
Cefuroxime (sodium)
Powder and solvent for solution for injection in glass vial
Powder for solution for injection/infusion in glass vial
Cis-atracurium Clindamycin Chlorhexidine
Aqueous cutaneous solution in plastic bottle and plastic ampoule
digluconate Chlorhexidine digluconate
Alcoholic 70% v/v cutaneous solution in plastic bottle
Dexclorpheniramine Dexketoprofen
Solution for injection/Concentrate for solution for infusion in glass
Flumazenil Gabapentin Glimepiride Granisetron
Concentrate for solution for injection in glass ampoule
Iron sucrose
Solution for injection/Concentrate for solution for infusion in glass
Sporanox® / Janssen-CilagItraconazole * Ketorolac trometamol Levofloxacin
Solution for infusion in glass vial/plastic bag
Linezolid * Memantine Meropenem
Powder for solution for injection in glass vial
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries
AVAILABLE DOSSIERS - Approved in at least one EU country
Midazolam Mirtazapine Pantoprazole
Lyophilised powder for solution/infusion in glass vial
Paracetamol Phenytoin Piperacillin/Tazobactam
Lyophilised powder and solvent for solution for infusion in glass vial
Lyophilised powder for solution for infusion in glass vial
Quetiapine IR Remifentanil
Lyophilised powder for solution for injection/infusion in glass vial
Solifenacin succinate Somatostatin
Lyophilised powder and solvent for solution for infusion in glass
Teicoplanin
Lyophilised powder and solvent for solution for injection in glass vial
Tobramycin
Solution for inhalation in plastic ampoule blow-fill-seal
Vancomycin
Lyophilised powder for solution for injection in glass vial
Venlafaxine IR Voriconazole *
Lyophilised powder for solution for infusion in glass vial
Zidovudine
Concentrate for solution for infusion in glass vial
Zoledronic acid
Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Availability may be restricted to certain markets or countries
Welcome to Spring 2009 Issue of the UK Clinical Ethics Network Newsletter Welcome to the UK Clinical Ethics Network Newsletter. Since our last newsletter in July 2008 we have been busy on a variety of fronts. As mentioned in the last newsletter the Network Board of Trustees commissioned Dr Martin Tweeddale to prepare a discussion document and proposal for a core curriculum for CECs. Marti
Swine Flu - Q&A Information sheet for Schools Swine Flu - Q&A Information sheet • Is it true there is a confirmed case of swine flu in Torbay? • Are schools likely to close? • What are the symptoms of swine flu? • Am I or my family at risk of getting swine flu? • What measures can I take to prevent infection? • What should Headteachers and managers